(Q40966508)

25 September 2017

1 reference

title

Neuropsychological consequences of antihypertensive medication use. (English)

1 reference

25 September 2017

1 reference

Muldoon MF

1

1 reference

PubMed ID

8595802

25 September 2017

Waldstein SR

series ordinal

2

1 reference

PubMed ID

8595802

25 September 2017

Jennings JR

series ordinal

3

1 reference

25 September 2017

1 October 1995

1 reference

Experimental Aging Research

25 September 2017

1 reference

25 September 2017

21

1 reference

25 September 2017

4

1 reference

25 September 2017

353-368

1 reference

Effects of the Beta-Adrenoceptor Blocking Agent Sotalol on CNS: Sleep, EEG, and Psychophysiological Parameters

25 September 2017

1 reference

https://api.crossref.org/works/10.1080%2F03610739508253990

Effect of beta-blockers on psychomotor performance in normal volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03610739508253990

Short-term behavioral effects of beta-adrenergic medications in men with mild hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03610739508253990

Three-week beta-adrenergic blockade does not impair or improve general intellectual function in young healthy males

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03610739508253990

Beta-adrenergic activation and memory for emotional events

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03610739508253990

Hypertensive black men and women. Quality of life and effects of antihypertensive medications. Black Hypertension Quality of Life Multicenter Trial Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03610739508253990

The effects of antihypertensive therapy on the quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03610739508253990

Cognitive effects of beta blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03610739508253990

The effect of high dose oxprenolol on stress-induced physical and psychophysiological variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03610739508253990

Cognitive processes in hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03610739508253990

The effect of beta-blockers on mental performance on older hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03610739508253990

Behavioral effects of diazepam and propranolol in patients with panic disorder and agoraphobia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03610739508253990

Treatment of hypertension in the elderly: II. Cognitive and behavioral function. Results of a Department of Veterans Affairs Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03610739508253990

The effects of four antihypertensive agents on the stroop colour-word test in normal male volunteer subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03610739508253990

Beta-adrenergic blockade in stress protection. Limited effect of metoprolol in psychological stress reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03610739508253990

Comparison of enalapril and atenolol in mild to moderate hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03610739508253990

Adverse effects of antihypertensive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03610739508253990

Central nervous system effects of beta-adrenergic-blocking drugs: the role of ancillary properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03610739508253990

CNS side effects of centrally-active antihypertensive agents: a prospective, placebo-controlled study of sleep, mood state, and cognitive and sexual function in hypertensive males

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03610739508253990

Effects of atenolol and propranolol on human performance and subjective feelings

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03610739508253990

Effects of antihypertensive therapy on blood pressure control, cognition, and reactivity. A placebo-controlled comparison of prazosin, propranolol, and hydrochlorothiazide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03610739508253990

Differential effects of atenolol and enalapril on memory during treatment for essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03610739508253990

Memory performance by mild hypertensives following beta-adrenergic blockade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03610739508253990

Neuropsychological deficits in arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03610739508253990

Psychotropic effects of enalapril maleate in normal volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03610739508253990

Relationship of age and hypertension to neuropsychological test performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03610739508253990

The effects of anti-hypertensive medication on learning and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03610739508253990

Central effects of single oral doses of propranolol in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03610739508253990

WAIS Performance for Different Age Groups of Hypertensive and Control Subjects during the Administration of a Diuretic

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03610739508253990

Impact of beta-blockade on complex cognitive functioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03610739508253990

Behavioral performance effects of antihypertensive drugs: human and animal studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03610739508253990

10.1080/03610739508253990

21 January 2018

Identifiers

DOI

1 reference

25 September 2017

1 reference

PubMed ID

8595802